From cell factories to patients: Stability challenges in biopharmaceuticals manufacturing and administration with mitigation strategies
- 30 August 2023
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 645, 123360
Abstract
No abstract availableKeywords
This publication has 178 references indexed in Scilit:
- Frozen-State Storage Stability of a Monoclonal Antibody: Aggregation is Impacted by Freezing Rate and Solute DistributionJournal of Pharmaceutical Sciences, 2013
- Stabilizing Additives Added during Cell Lysis Aid in the Solubilization of Recombinant ProteinsPLOS ONE, 2012
- Chemical Modifications in Aggregates of Recombinant Human Insulin Induced by Metal-Catalyzed Oxidation: Covalent Cross-Linking via Michael Addition to Tyrosine Oxidation ProductsPharmaceutical Research, 2012
- Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of ImmunogenicityPharmaceutical Research, 2011
- Prevention of benzyl alcohol-induced aggregation of chymotrypsinogen by PEGylationJournal of Pharmacy and Pharmacology, 2011
- Histidine Residue Mediates Radical-induced Hinge Cleavage of Human IgG1Journal of Biological Chemistry, 2010
- Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous SolutionJournal of Pharmaceutical Sciences, 2009
- Cytotoxicity of Insulin within its Self-assembly and Amyloidogenic PathwaysJournal of Molecular Biology, 2007
- Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectantProceedings of the National Academy of Sciences, 2006
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003